Sanofi's oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib has gained US Food and Drug Administration ...

US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...

Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...

a CD20-directed bispecific antibody currently being evaluated in a Phase 1 trial in B-cell non-Hodgkin lymphoma patients and is expanding into various autoimmune indications. The drug candidate ...

The Dren Bio therapy is part of a growing trend of research into autoimmune disease medicines that can reset the immune system instead of suppressing it. The work is built on promising results in ...

Over the past couple of years, there have been questions and counter-questions when it comes to anaemia in India. Is it being over-diagnosed? Are the cut-offs that are being tested for not ...

An antibody treatment from Immunovant and Roivant Sciences significantly reduced symptoms and disease activity in patients with generalized myasthenia gravis, a debilitating autoimmune disease ...

Type 2 diabetes is not an autoimmune condition, while type 1 diabetes is. Though new research suggests the immune system may be involved in type 2 diabetes, its causes are more closely linked to other ...

Researchers say that exposure to foodborne illness can also trigger autoimmune disease. Autoimmune diseases occur if a person’s immune system mistakenly attacks healthy cells or organs ...

Their findings could open new pathways for treating autoimmune diseases and enhancing cancer immunotherapy. A research team led by Rice University's Yang Gao has uncovered new insights into the ...

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. Medical history made at Cohen Children's Medical ...